Why the study?
Does bivalirudin plus provisional GPI reduce blood transfusion, repeated PCI, and in-hospital death in individuals undergoing inpatient PCI compared to heparin plus GPI?
Does bivalirudin plus provisional GPI reduce blood transfusion, repeated PCI, and in-hospital death in individuals undergoing inpatient PCI compared to heparin plus GPI?
In routine clinical practice, the use of bivalirudin during PCI is associated with significant reductions in blood transfusions and in-hospital mortality compared to heparin plus GPI.
No takes yet. Share an insight, caveat, or question.
Bivalirudin may lower transfusion and mortality risk during PCI; hypothesis-generating and requires randomized confirmation.
Rassen et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: